{"name":"Catalyst Biosciences","slug":"catalyst-biosciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":275000,"revenueGrowth":116.5,"grossMargin":0,"rdSpend":13698000,"netIncome":9880000,"cash":166132000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2014"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxNanRobzAyR0tPeS1qWEM0SjBkaUh5NmlmeWx5dVUwYXNFTU0zM25VT1ZVMWRGc0tnc3liQ2xIdmIxZ0dTTFV5VlJpUXBPZVJiRGEzT1d6NHdPMUVWWGtua2M1WlMtZGJnNi03TWpCa0VrRFRXTEQxUVVDRzBOSjVjUHV4djNrVG02cFZHSzc4UE5GWXVPamZEWmlDdkxRaW1MS3lLdmNjcUZOZThVOG5ZUXpod0FHMFRFdWltclBhUS1lUUMtZ0hUZkprMFRQbXJxYkluZ2tDWFZrY3pTYWZMVTV2dVBuUnhaT3JHTWpiNHJBei1ZYURmOWxBc0Q1OVhacmFHQ1ZNMEdwWFEtWi1YVmtNR1NUODVMQlBLdkhIR1BCaWxFWExzTVN3?oc=5","date":"2026-03-31","type":"pipeline","source":"Barchart.com","summary":"Hemophilia B Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharma, CSL Behring, uniQure, Novo Nordisk - Barchart.com","headline":"Hemophilia B Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Pfizer, Spark Therapeutics, Sanofi, A","sentiment":"neutral"},{"date":"2026-03-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-13","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPQmQ5U2p4RkZmWWQxU0tWcWxxNHRORkNGRGxSYzFyTlRvUHprMUZNLVBic21JallxR213NVVGc2Q4RFZVYUpjTWlqekYwVXFaOGNzSFk5eDg4YkhxOWozVlNOSXFsY0l5dFUtWFRxaVpJTzBNMUhWclkwRUlydXkxQVEyWjVLcE5QV0pGNFpqamNCZHN1NzJ5bi1LeF9zalBUQ3h1QzVVeWdGX3lLVWNYaTJ4Si0?oc=5","date":"2026-02-18","type":"pipeline","source":"Pharmaceutical Executive","summary":"From Sun Belt Boom to Biotech Hub: Why Southern Florida’s Moment has Arrived - Pharmaceutical Executive","headline":"From Sun Belt Boom to Biotech Hub: Why Southern Florida’s Moment has Arrived","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNZUo5eHNRRFFsZVV0MHRLTXJ2QWZMbVZRNmE2MEN5RGdob3d6SFNiVEZSbm9pLWVSNTJiYTdmNGVfdlVhQlludktKZUhLMmZPQjFVbXE0aWJveHdEY2VXdElINjg1QWFsbURfOTk2cU5iTWg4T0tGZXNkV0FPRWFwSmFsTTFPS1dnUlBzT2RDU3E3U0pSSTJF?oc=5","date":"2026-01-09","type":"pipeline","source":"Yahoo Finance","summary":"Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Recent Share Price Pause? - Yahoo Finance","headline":"Is Catalyst Pharmaceuticals (CPRX) Still Attractive After Recent Share Price Pause?","sentiment":"neutral"},{"date":"2026-01-05","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNOVFLMlBQWWVZUk5kTHFLX3ZNZ2g5dURBMzdqRVduOUpmZGpwZFZXSDNRTDVWdHpaNHRyb2NtQlpKWkMwbnVEMVNPUFRsZDc4WmZvazFOTzRSN1ZhQlVLaDRCY2lTOGl1VzZRYWZhTmk5VGttSEdUZmJXdkNpRUl3bVh2ZUVzMlN4ZWdhVHdrNXd4bnE2RmJOYWpvSVl6Um9nRlBiVDJ2UWVUQ1pJbVh0LWhTT0UxZw?oc=5","date":"2025-11-25","type":"pipeline","source":"Seeking Alpha","summary":"Ideaya Biosciences: Primed For Success - Major Eye Cancer Catalyst Weeks Away (IDYA) - Seeking Alpha","headline":"Ideaya Biosciences: Primed For Success - Major Eye Cancer Catalyst Weeks Away (IDYA)","sentiment":"neutral"},{"date":"2025-11-07","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-11-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-09-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-08-22","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":275000,"revenuePeriod":"2014-12-31","revenueHistory":[{"value":275000,"period":"2014-12-31"},{"value":127000,"period":"2014-12-31"},{"value":25000,"period":"2014-09-30"},{"value":36000,"period":"2014-06-30"},{"value":87000,"period":"2014-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":13698000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":9880000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":166132000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}